Anbio Biotechnology Selling, General and Administrative Expense
Anbio Biotechnology (NNNN) reported Selling, General and Administrative Expense of $1.57 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-04-07
| Period end | Selling, General and Administrative Expense 12 month |
|---|---|
| 2025-12-31 | $1.57M 20-F · filed 2026-04-07 |
| 2024-12-31 | $3.44M 20-F · filed 2026-04-07 |
| 2023-12-31 | $1.27M 20-F · filed 2026-04-07 |
| 2022-12-31 | $2.17M 20-F · filed 2025-04-28 |